At CHL, all coronavirus patients receive Dexamethasone. Dr Staub from the infectious diseases department conveyed that it was nevertheless no magical treatment.

Luxembourg's hospitals are again recording higher numbers of virus patients. The number of fatal cases has remained steady as most new confirmed infections have been reported among younger people.Dr Staub nevertheless underlined that, if numbers continue to climb, the country could face difficult times.
Back in March, it was still relatively unknown which drugs would be efficient in the treatment of Covid-19 symptoms. During that first phase, doctors mainly focused on applying the same methodology used for the Middle East respiratory syndrome-related coronavirus. Researchers have made considerable progress since. The beneficial use of hydroxychloroquine has been debunked, same as Caletra, an HIV treatment. Dr Staub emphasised that CHL did no longer use any of the above mentioned drugs. Patients with severe symptoms are encouraged to participate in the "Discovery" study.

Dr Staub further elaborated: "Only patients receiving artificial respiratory support are eligible to participate. They will be treated with Remdevisir, which is actually an Ebola drug." Patients will also receive preventive care concerned with thrombosis, a previously unknown side-effect of the coronavirus.

By now, every patient is treated with Dexamethasone, since a British study confirmed that the drug could reduce the mortality rate. Dr Staub remains cautious nonetheless: "It is no wonder drug, it is only used for its anti-inflammatory effects." Remdesivir on the other hand only affects the duration of the illness, not the mortality rate.

CHL also considers other treatment methods that have shown promising results in international studies.

"If numbers continue to climb, the country will face a difficult time"

Dr Staub regrets that the country's number of new infections is on the rise again, same as the amount of hospital patients: "Out of 100 new infections, about 10% will be admitted to a hospital for treatment. If the numbers continue, our health sector will have problems in the not too distant future."

People are thus supposed to be responsible in their behaviour and reduce physical contacts to a minimum. The illness is not to be underestimated: "There are currently two patients in intensive care that are only 40 years old."

The tent outside of CHL will not be taken down as scheduled, but remain in place.